Transforming Growth Factor‐β‐Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria—Identification of a New Therapeutic Target

Karina A. Zeyer, Stefan Tholen, Oliver Schilling, Leonie Gerling, Marina Morath, Stefan Kölker, Alexander Nyström, Ute Spiekerkoetter, Anke Schumann

Open source

DOI
10.1002/jimd.70111
Published
2025-10-25
Container
Journal of Inherited Metabolic Disease
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jimd.70111,
  title = {Transforming Growth Factor‐β‐Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria—Identification of a New Therapeutic Target},
  author = {Karina A. Zeyer and Stefan Tholen and Oliver Schilling and Leonie Gerling and Marina Morath and Stefan Kölker and Alexander Nyström and Ute Spiekerkoetter and Anke Schumann},
  year = {2025},
  journal = {Journal of Inherited Metabolic Disease},
  doi = {10.1002/jimd.70111},
  url = {https://doi.org/10.1002/jimd.70111}
}

RIS

TY  - JOUR
TI  - Transforming Growth Factor‐β‐Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria—Identification of a New Therapeutic Target
AU  - Karina A. Zeyer
AU  - Stefan Tholen
AU  - Oliver Schilling
AU  - Leonie Gerling
AU  - Marina Morath
AU  - Stefan Kölker
AU  - Alexander Nyström
AU  - Ute Spiekerkoetter
AU  - Anke Schumann
PY  - 2025
JO  - Journal of Inherited Metabolic Disease
DO  - 10.1002/jimd.70111
UR  - https://doi.org/10.1002/jimd.70111
ER  - 

APA

Zeyer, K. A., Tholen, S., Schilling, O., Gerling, L., Morath, M., Kölker, S., Nyström, A., Spiekerkoetter, U., & Schumann, A. (2025). Transforming Growth Factor‐β‐Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria—Identification of a New Therapeutic Target. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70111

Source records